Zobrazeno 1 - 2 of 2 pro vyhledávání: '"Ashwaq Aljuraysi"'
1
Akademický článek
Transcriptome analysis of neratinib treated HER2 positive cancer model vs untreated cancer unravels the molecular mechanism of action of neratinib
Autor: Sara Alkhezayem, Tanveer A. Wani, Salma Wakil, Ashwaq Aljuraysi, Seema Zargar
Publikováno v: Saudi Pharmaceutical Journal, Vol 28, Iss 8, Pp 963-970 (2020)
Human estrogen receptor positive cancer cells have mutations and make an excess of the HER2 protein and are far more aggressive than others cancers. Neratinib, an irreversible tyrosine kinase inhibitor is used to treat HER2 positive cancers. Neratini
Externí odkaz: https://doaj.org/article/a3fd516796aa499fa070253e79e8fb14
Zobrazit plný text záznamu
2
Transcriptome analysis of neratinib treated HER2 positive cancer model vs untreated cancer unravels the molecular mechanism of action of neratinib
Autor: Seema Zargar, Tanveer A. Wani, Ashwaq Aljuraysi, Sara Alkhezayem, Salma Wakil
Publikováno v: Saudi Pharmaceutical Journal, Vol 28, Iss 8, Pp 963-970 (2020)
Saudi Pharmaceutical Journal : SPJ
Human estrogen receptor positive cancer cells have mutations and make an excess of the HER2 protein and are far more aggressive than others cancers. Neratinib, an irreversible tyrosine kinase inhibitor is used to treat HER2 positive cancers. Neratini
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f563a230ec051cfe0203f5e99c70a9
http://www.sciencedirect.com/science/article/pii/S1319016420301365
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje